Clinical Trial Update: Clinical Evaluation Of The Nano Lv Lead System In Chronic Situation (LENEA) [Phase 2, Phase 3]

View source ↗

Summary

Clinical trial LENEA evaluated the Nano LV Lead System for chronic heart failure in Phase 2 and Phase 3 and has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Heart Failure

Snippet

Sponsor: LivaNova | Conditions: LV Lead, LV Therapy | Phase 2, Phase 3 | Status: TERMINATED